Market Closed -
Japan Exchange
11:30:00 10/05/2024 am IST
5-day change
1st Jan Change
5,992
JPY
-0.55%
-3.68%
+33.93%
Ain : IR Presentation FY4/23
June 07, 2023 at 12:22 pm IST
© 2023 AIN HOLDINGS INC. All Rights Reserved.
1
Consolidated P/L
Net sales increased 13.4% YoY and 0.2% against the plan due to new store openings and contribution of existing stores, despite the impact of the COVID-19. Ordinary profit increased 6.4% YoY and declined 5.4% against the plan due to increase of sales.
FY4/22
FY4/23
results
revised plan
YoY
YoY
Vs plan
change
change(%)
(%)
Net sales
316,247
358,000
358,742
+ 42,495
+ 13.4
+ 0.2
Gross profit
49,971
54,870
53,698
+ 3,727
+ 7.5
(2.1)
% of net sales
15.8
15.3
15.0
SG&A expenses
34,832
37,690
37,694
+ 2,862
+ 8.2
+ 0.0
% of net sales
11.0
10.5
10.5
Operating profit
15,139
17,180
16,004
+ 865
+ 5.7
(6.8)
% of net sales
4.8
4.8
4.5
Ordinary profit
16,041
18,030
17,064
+ 1,023
+ 6.4
(5.4)
% of net sales
5.1
5.0
4.8
Profit attributable to
7,092
9,000
9,234
+ 2,142
+ 30.2
+ 2.6
owners of parent
% of net sales
2.2
2.5
2.6
Earnings per
201.47
256.20
262.87
+ 61.40
+ 30.5
+ 2.6
share(¥)
Figures in the table are rounded down
© 2023 AIN HOLDINGS INC. All Rights Reserved.
2
Dispensing Pharmacy Business (Consolidated)
Net sales increased 13.6% YoY and 0.0% against the plan due to new store openings including M&A and contribution of stores opened previous year. Segment profit declined 3.8% YoY and 5.4% against the plan.
FY4/22
FY4/23
results
revised plan
YoY
YoY
Vs plan
change
change(%)
(%)
Net sales
283,111
321,560
321,577
+ 38,466
+ 13.6
+ 0.0
Gross profit
38,194
41,350
39,779
+ 1,585
+ 4.1
(3.8)
% of net sales
13.5
12.9
12.4
SG&A expenses
13,875
16,620
16,559
+ 2,684
+ 19.3
(0.4)
% of net sales
4.9
5.2
5.1
Operating profit
24,319
24,730
23,220
(1,099)
(4.5)
(6.1)
% of net sales
8.6
7.7
7.2
Segment profit
25,082
25,520
24,135
(947)
(3.8)
(5.4)
% of net sales
8.9
7.9
7.5
Number of
1,099
1,210
1,209
+ 110
+ 10.0
(0.1)
pharmacies
Figures in the table are rounded down
© 2023 AIN HOLDINGS INC. All Rights Reserved.
3
Cosmetic and Drug Store Business (Consolidated)
Net sales increased 24.9% YoY and 3.1% against the plan due to the recovery of existing stores, contribution of stores opened in previous year, and success of cost optimization despite the impact of the COVID-19. Segment profit was 38% against the plan, ¥2,978 million above the plan.
FY4/22
FY4/23
results
revised plan
YoY
YoY
Vs plan
Change
change(%)
(%)
Net sales
20,558
24,920
25,685
+ 5,127
+ 24.9
+ 3.1
Gross profit
7,030
9,410
9,694
+ 2,664
+ 37.9
+ 3.0
% of net sales
34.2
37.8
37.7
SG&A expenses
8,858
8,570
8,521
(337)
(3.8)
(0.6)
% of net sales
43.1
34.4
33.2
Operating profit
(1,827)
840
1,172
+ 2,999
-
+ 39.5
% of net sales
-
3.4
4.6
Segment profit
(1,764)
880
1,214
+ 2,978
-
+ 38.0
% of net sales
-
3.5
4.7
Number of
78
78
78
0
0.0
0.0
stores
Figures in the table are rounded down
© 2023 AIN HOLDINGS INC. All Rights Reserved.
4
Attachments
Original Link
Original Document
Permalink
Disclaimer
AIN Holdings Inc. published this content on 07 June 2023 and is solely responsible for the information contained therein. Distributed by Public , unedited and unaltered, on 07 June 2023 06:51:03 UTC .
Tranche Update on Ain Holdings Inc.'s Equity Buyback Plan announced on April 3, 2024.
23/04
CI
Ain Holdings Inc.'s Equity Buyback announced on April 3, 2024, has closed with 100,000 shares, representing 0.28% for ¥591.73 million.
22/04
CI
Sapporo Court Suspends Sentence of Ain's Two Ex-Directors
19/04
MT
Ain Holdings Initiates 600 Million Yen Buyback
04/04
MT
Ain Holdings Inc. announces an Equity Buyback for 100,000 shares, for ¥600 million.
03/04
CI
Ain Holdings Inc. authorizes a Buyback Plan.
03/04
CI
Ain Holdings Inc.(TSE:9627) dropped from FTSE All-World Index
18/03
CI
Shares in Japan's Ain soar after activist fund Oasis buys 9.6% stake
06/03
RE
Ain Holdings Inc. Provides Dividend Guidance for the Year Ending April 30, 2024
01/03
CI
Ain Holdings Inc. Provides Dividend Guidance for the Year Ending April 30, 2024
06/12
CI
Ain Holdings Inc. Provides Earnings Guidance for the Fiscal Year Ending April 30, 2024
06/12
CI
Ain Holdings Inc. Provides Consolidated Earnings Guidance for the First Half Year and Full Year Ending April 30, 2024
01/23/01
CI
Ain Holdings Inc. Provides Dividend Guidance for the Year-Ending April 30, 2024
01/23/01
CI
Ain Holdings Inc. Provides Dividend Guidance for the Year-End April 30, 2024
02/23/02
CI
Ain Holdings Inc. Announces Dividend for the Year-Ended April 30, 2023, Payable on July 31, 2023
02/23/02
CI
Ain Holdings Inc. Provides Consolidated Earnings Guidance for the First Half Year and Full Year Ending April 30, 2024
02/23/02
CI
Ain Holdings Inc. Announces Management Retirements
26/23/26
CI
Ain Holdings Inc. Revises Consolidated Earnings Guidance for the Year Ending April 30, 2023
03/23/03
CI
Ain Holdings Inc. Provides Dividend Guidance for the Year-End April 30, 2023
02/22/02
CI
Ain Holdings Inc. Provides Consolidated Earnings Guidance for the First Half Year and Full Year Ending April 30, 2023
02/22/02
CI
Ain Holdings Inc. Provides Dividend Guidance for the Year-End April 30, 2023
03/22/03
CI
Ain Holdings Inc. Announces Dividend for the Year-Ended April 30, 2022, Payable on July 29, 2022
03/22/03
CI
Ain Holdings Inc. Provides Consolidated Earnings Guidance for the First Half Year and Full Year Ending April 30, 2023
03/22/03
CI
Ain Holdings to Takeover Pharmacy Chain
10/22/10
MT
Ain Holdings Inc. agreed to acquire Pharmacy Holdings Co., Ltd.
09/22/09
CI
Duration Auto. 2 months 3 months 6 months 9 months 1 year 2 years 5 years 10 years Max.
Period Day Week
More charts
Ain Holdings Inc, is a Japan-based company engaged in the operation of pharmacies and retail business. The Company has three business segments. The Pharmacy segment operates and franchises pharmacies, and provides consulting services related to opening pharmacies. Through its subsidiaries, this segment is also involved in the provision of consultation services for medical-related affairs and manpower dispatching of doctors and pharmacists, as well as the sale of generic drugs. The Retail segment operates cosmetics business and drugstores. The Others segment is engaged in the leasing of buildings and the sales of cosmetics.
More about the company
Last Close Price
5,992
JPY
Average target price
5,370
JPY
Spread / Average Target
-10.38%
Consensus
1st Jan change
Capi.
+33.93% 1.35B -12.76% 8.54B +11.65% 443M +2.22% 274M +13.33% 232M -5.50% 88.89M -46.03% 83.22M +19.24% 59.31M
Retail - Drugs without Grocery
+951% of historical performance
More than 20 years at your side
Our Experts are here for you
OUR EXPERTS ARE HERE FOR YOU
Monday - Friday 9am-12pm / 2pm-6pm GMT + 1